The PE Ratio as of November 2024 (TTM) for Enochian Biosciences, Inc. (ENOB) is -0.34

According to Enochian Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.34. This represents a change of -92.78% compared to the average of -4.77 of the last 4 quarters.

Enochian Biosciences, Inc. (ENOB) Historical PE Ratio (quarterly & annually)

How has ENOB PE Ratio performed in the past?

The mean historical PE Ratio of Enochian Biosciences, Inc. over the last ten years is -12.94. The current -0.34 PE Ratio has changed 166.04% with respect to the historical average. Over the past ten years (40 quarters), ENOB's PE Ratio was at its highest in in the June 2022 quarter at -0.28. The PE Ratio was at its lowest in in the March 2022 quarter at -17.51.

Enochian Biosciences, Inc. (ENOB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Enochian Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enochian Biosciences, Inc. (ENOB) Average PE Ratio

How has ENOB PE Ratio performed in the past?

The current PE Ratio of Enochian Biosciences, Inc. (ENOB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Enochian Biosciences, Inc. (ENOB) PE Ratio vs. Peers

How is ENOB’s PE Ratio compared to its peers?

Enochian Biosciences, Inc.’s PE Ratio is greater than Aerovate Therapeutics, Inc. (-0.91), greater than Adagene Inc. (-3.02), greater than Acrivon Therapeutics, Inc. Common Stock (-3.24), greater than Rezolute, Inc. (-4.94), greater than AN2 Therapeutics, Inc. (-0.66), greater than Molecular Partners AG (-2.50), greater than Mineralys Therapeutics, Inc. (-4.06), greater than Pharvaris N.V. (-8.69), greater than PepGen Inc. (-1.65), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than PMV Pharmaceuticals, Inc. (-1.61), less than MediciNova, Inc. (-0.04), greater than Champions Oncology, Inc. (-18.21), greater than Cyteir Therapeutics, Inc. (-9.12), greater than Eliem Therapeutics, Inc. (-2.42),

Build a custom stock screener for Enochian Biosciences, Inc. (ENOB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enochian Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enochian Biosciences, Inc. (ENOB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enochian Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.